The farmaceutical group GSK has recently unveiled promising outcomes from its phase AReSVi-006 trial (Adult Respiratory Syncytial Virus). The study, which assessed the efficacy...
A study conducted by researchers at Harvard Medical School and published in the medical journal JAMA revealed that immunity from the Mpox vaccine would...
According to the WHO Weekly Bulletin on Outbreak and other Emergencies (Week 40: 30 September to 6 October 2024), Ethiopia is confronting a considerable...